William Huyett, Chief Financial Officer at Cyclerion Therapeutics, Inc. (CYCN), sold 3,827 shares at $2.52 ($10K) on 2020-11-06, disclosed to the SEC on 2020-11-10.
Scheduled sale ($10k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CYCN | SELL | 2019-11-12 | $8K | — | Filing → |